iCamuno Biotherapeutics
艾凯生物
iCamuno Biotherapeutics
Biotech/Healthcare
Aikailiyuan develops next-generation, universal off-the-shelf cell therapies. Guided by the principle of conducting patient-centered drug development based on clinical needs, the company has built deep technical expertise in iPSC reprogramming, gene editing, and stem cell differentiation, and has…
Latest round: Series A Extension (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.